GSK’s daprodustat, which is sold under the brand name Jesduvroq, has been granted class-first approval following two previous FDA rejections for oral anemia medications in the hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI) drug class. The drug is specifically approved for the treatment of chronic kidney disease patients with anemia who have been on dialysis for […]
Continue Reading
GSK Plc. Announced that, the Food and Drug Administration (FDA) of the United States has now approved Priorix for the active immunisation to prevent the individuals from measles, mumps and rubella (MMR), which are 12 months of age and older. Priorix has currently been licenced in over 100 countries across the world including all the […]
Continue Reading
The European Union and GlaxoSmithKline (GSK) has recently signed a contract for the purpose of supplying around 220,000 treatments of the European Union’s monoclonal antibody therapy against the novel corona virus. According to the European Commission, the covid-19 drug, that has been developed together with the company Vir Biotechnology based in the United States can […]
Continue Reading